Department of Cardiology, Bern University Hospital, Inselspital, University of Bern, Freiburgstrasse 18, 3010 Bern, Switzerland.
Department of Cardiology, University Heart Center, University Hospital Zürich, Rämistrasse 100, 8091 Zürich, Switzerland.
Eur Heart J Acute Cardiovasc Care. 2023 Jun 2;12(6):376-385. doi: 10.1093/ehjacc/zuad033.
Routine revascularization in patients with ST-segment elevation myocardial infarction (STEMI) presenting >48 h after symptom onset is not recommended.
We compared outcomes of STEMI patients undergoing percutaneous coronary intervention (PCI) according to total ischaemic time. Patients included in the Bern-PCI registry and the Multicenter Special Program University Medicine ACS (SPUM-ACS) between 2009 and 2019 were analysed. Based on symptom-to-balloon-time, patients were categorized as early (<12 h), late (12-48 h), or very late presenters (>48 h). Co-primary endpoints were all-cause mortality and target lesion failure (TLF), a composite of cardiac death, target vessel myocardial infarction, and target lesion revascularization at 1 year. Of 6589 STEMI patients undergoing PCI, 73.9% were early, 17.2% late, and 8.9% very late presenters. The mean age was 63.4 years, and 22% were female. At 1 year, all-cause mortality occurred more frequently in late vs. early [5.8 vs. 4.4%, hazard ratio (HR) 1.34, 95% confidence interval (CI) 1.01-1.78, P = 0.04] and very late (6.8%) vs. early presenters (HR 1.59, 95% CI 1.12-2.25, P < 0.01). There was no excess in mortality comparing very late and late presenters (HR 1.18, 95% CI 0.79-1.77, P = 0.42). Target lesion failure was more frequent in late vs. early (8.3 vs. 6.5%, HR 1.29, 95% CI 1.02-1.63, P = 0.04) and very late (9.4%) vs. early presenters (HR 1.47, 95% CI 1.09-1.97, P = 0.01), and similar between very late and late presenters (HR 1.14, 95% CI 0.81-1.60, P = 0.46). Following adjustment, heart failure, impaired renal function, and previous gastrointestinal bleeding, but not treatment delay, were the main drivers of outcomes.
PCI >12 h after symptom onset was associated with less favourable outcomes, but very late vs. late presenters did not have an excess in events. While benefits seem uncertain, (very) late PCI appeared safe.
不建议对症状发作后 >48 小时出现 ST 段抬高型心肌梗死(STEMI)的患者进行常规血运重建。
我们比较了根据总缺血时间接受经皮冠状动脉介入治疗(PCI)的 STEMI 患者的结局。对 2009 年至 2019 年期间 Bern-PCI 注册中心和多中心特殊计划大学医学急性冠脉综合征(SPUM-ACS)纳入的患者进行分析。根据症状至球囊时间,患者被分为早期(<12 小时)、晚期(12-48 小时)或极晚期(>48 小时)。主要终点为全因死亡率和靶病变失败(TLF),定义为 1 年内的心脏死亡、靶血管心肌梗死和靶病变血运重建的复合终点。在 6589 例行 PCI 的 STEMI 患者中,73.9%为早期,17.2%为晚期,8.9%为极晚期。平均年龄为 63.4 岁,22%为女性。1 年时,晚期患者的全因死亡率高于早期[5.8% vs. 4.4%,风险比(HR)1.34,95%置信区间(CI)1.01-1.78,P=0.04]和极晚期(6.8%)[HR 1.59,95%CI 1.12-2.25,P<0.01]。极晚期和晚期患者之间的死亡率无差异(HR 1.18,95%CI 0.79-1.77,P=0.42)。晚期患者的靶病变失败发生率高于早期[8.3% vs. 6.5%,HR 1.29,95%CI 1.02-1.63,P=0.04]和极晚期(9.4%)[HR 1.47,95%CI 1.09-1.97,P=0.01],极晚期和晚期患者之间无差异(HR 1.14,95%CI 0.81-1.60,P=0.46)。校正后,心力衰竭、肾功能不全和既往胃肠道出血,而非治疗延迟,是结局的主要驱动因素。
症状发作后 12 小时以上行 PCI 与预后不良相关,但极晚期与晚期患者之间无不良事件增加。虽然获益似乎不确定,但(极)晚期 PCI 似乎是安全的。